In February 2026, the U.S
Cendakimab, a high-affinity monoclonal antibody, binds IL-13, blocking interaction with receptors IL-13 receptor alpha 1 and IL-13 receptor alpha 2
Butyrate, acetate, and propionate are the main SCFAs
But as a Wired article from August put it, the Ozempic-adjacent supplement gold rush is just getting started. Because of how these drugs work, their desired effects and their many unpleasant side effects, supplements can indeed be a key component of the GLP-1 journey
Just like losing large amounts of weight can cause bagginess and sagging around your stomach and arms, you can also see that droopiness around your face, jaw, and neck